Supplementary Figure 2 from Neoadjuvant Enzalutamide Prior to Prostatectomy

التفاصيل البيبلوغرافية
العنوان: Supplementary Figure 2 from Neoadjuvant Enzalutamide Prior to Prostatectomy
المؤلفون: Mary-Ellen Taplin, Alison Hannah, Andrew Krivoshik, Gabriel P. Haas, Adam Kibel, Rosina T. Lis, Alvin M. Matsumoto, Peter S. Nelson, Steven P. Balk, Stephen Plymate, Brett T. Marck, Philip W. Kantoff, Kenneth Wu, William Novotny, Martin Sanda, Daniel W. Lin, Kim N. Chi, Elahe A. Mostaghel, Glenn J. Bubley, Neil Fleshner, Martin E. Gleave, Anthony M. Joshua, Maria S. Tretiakova, Bruce Montgomery
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Prostate androgen levels after enza or enza/dut/LHRHa. Tissue androgens from prostatectomy specimens after 6 months of therapy were measured by mass spectroscopy to determine levels of (A) pregnenolone, (B) progesterone, (C) DHEA, (D) AED, (E) testosterone, and (F) DHT. P values were calculated using the nonparametric Mann-Whitney test. Limits of quantification were 0.015 pg/mg for AED, progesterone, and testosterone, 0.03 pg/mg for DHT and pregnenolone, and 0.49 pg/mg for DHEA.
DOI: 10.1158/1078-0432.22463937
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::067d1a10f3a0b443d886c076b3340281
https://doi.org/10.1158/1078-0432.22463937
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....067d1a10f3a0b443d886c076b3340281
قاعدة البيانات: OpenAIRE
الوصف
DOI:10.1158/1078-0432.22463937